Ramon Font
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramon Font has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Martinez-Vea
Nephrology Service.Hospital Universitari de Tarragona Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain
1 shared publication - C. Garcia-Ruiz
Nephrology Service.Hospital Universitari de Tarragona Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain
1 shared publication - Carmen Cabré
Nephrology Service.Hospital Universitari de Tarragona Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain
1 shared publication - Manel Jariod
Information Systems Department, Hospital Joan XXIII, Tarragona, Spain
1 shared publication - Merche Prats
Servicio de Nefrología, Hospital Universitari de Tarragona Joan XXIII, Carrer del Doctor Mallafré Guasch 4, 43007, Tarragona, Spain
1 shared publication
Latest Publications
- Open Access
- 31 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 167
Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
Some parenteral iron therapies have been found to be associated with hypophosphatemia. The mechanism of the decrease in serum phosphate is unknown. The aim of this study is to examine the effect of IV ferric carboxymaltose(FCM) on phosphate metabolism and FGF23 levels in patients with chronic kidney disease(CKD).
- 31 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 167
Open AccessEffect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
Some parenteral iron therapies have been found to be associated with hypophosphatemia. The mechanism of the decrease in serum phosphate is unknown. The aim of this study is to examine the effect of IV ferric carboxymaltose(FCM) on phosphate metabolism and FGF23 levels in patients with chronic kidney disease(CKD).